See also this year's filing and all EDGAR filings for this company.
PDF Report 0001052284_2013_Tongli_Pharmaceuticals_USA_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001052284, Tongli Pharmaceuticals USA Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,137,391 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,041,032 |
| 2 | PropertyPlantAndEquipmentNet | 6,193,526 |
| 3 | remainder_Assets | 469,726 |
| 4 | LiabilitiesCurrent | 1,500,843 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,724,711 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 11,586,467 |
| 11 | remainder_Revenues | 15,487,083 |
| 12 | remainder_NetIncome | -24,133 |
| 13 | remainder_ComprehensiveNetIncome | 371,822 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 19,841,675 |
| 1 | Liabilities | 1,500,843 |
| 2 | Expenses | 13,311,178 |
| 3 | Revenues | 15,487,083 |
| 4 | StockholdersEquity | 18,340,832 |
| 5 | NetIncome | 2,151,772 |
| 6 | ComprehensiveNetIncome | 2,337,683 |
| 7 | BaseVar | 25,268,367 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.97 |
| 9 | EconomicCapitalRatio | 4.37 |